MediPharm Labs Corp. (TSX:LABS)

MediPharm Labs Income Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	45.12	41.96	33.06	22.12	21.71
Revenue Growth (YoY)	7.54%	26.92%	49.49%	1.87%	-39.71%
Cost of Revenue	31.56	28.47	28.4	24.03	36.96
Gross Profit	13.56	13.49	4.67	-1.91	-15.25
Selling, General & Admin	21.98	23.2	23.33	25.72	31.24
Research & Development	0.22	0.24	0.21	1	1.36
Other Operating Expenses	-0.21	0.86	-0.62	0.9	1.07
Total Operating Expenses	22	24.3	22.92	27.62	33.67
Operating Income	-8.44	-10.81	-18.25	-29.53	-48.92
Interest Income	0.23	0.69	0.84	0.48	0.23
Interest Expense	-0.06	-0.58	-0.37	-0.03	-10.51
Other Non-Operating Income (Expense)	-	-	4.42	-0.9	4.51
Total Non-Operating Income (Expense)	0.17	0.12	4.89	-0.46	-5.77
Pretax Income	-8.27	-10.69	-13.36	-29.99	-54.69
Provision for Income Taxes	-	-	0.28	0.01	-0.11
Net Income	-8.27	-10.69	-13.08	-29.98	-54.8
Net Income to Common	-8.27	-10.69	-13.08	-29.98	-54.8
Shares Outstanding (Basic)	418	408	363	277	250
Shares Outstanding (Diluted)	418	408	363	277	250
Shares Change (YoY)	2.53%	12.29%	31.23%	10.79%	80.37%
EPS (Basic)	-0.02	-0.03	-0.04	-0.11	-0.22
EPS (Diluted)	-0.02	-0.03	-0.04	-0.11	-0.22
Shares Outstanding	418.32	407.99	401.4	282.17	273.54
Free Cash Flow	-5.6	-5.02	-12.81	-16.93	-14
Free Cash Flow Per Share	-0.01	-0.01	-0.04	-0.06	-0.06
Gross Margin	30.06%	32.15%	14.12%	-8.65%	-70.22%
Operating Margin	-18.70%	-25.76%	-55.21%	-133.53%	-225.31%
Profit Margin	-18.32%	-25.49%	-39.57%	-135.56%	-252.41%
FCF Margin	-12.42%	-11.95%	-38.75%	-76.56%	-64.46%
EBITDA	-6.78	-8.21	-15.74	-26.66	-43.28
EBITDA Margin	-15.02%	-19.56%	-47.60%	-120.54%	-199.36%
EBIT	-8.44	-10.81	-18.25	-29.53	-48.92
EBIT Margin	-18.70%	-25.76%	-55.21%	-133.53%	-225.31%
Effective Tax Rate	0.00%	0.00%	-2.07%	-0.02%	0.21%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.